The AI Summit New York

2023 Agenda


How will AI transform drug discovery and what challenges we need to account for?

Dec 06, 2023
Room 1A14
Industries Stage
  • Benefits of AI-powered drug making include increased volume and speed to market, as AI algorithms facilitate efficient analysis of biological datasets and aid in target identification, virtual screening, and drug design
  • However, challenges associated with AI-powered drug making are plentiful – how do we address and tackle those in a timely manner?
  • What are industry leaders doing in this space?
Andrew Brosnan, Principal Analyst - Omdia
Nikhil Pradhan, Senior Counsel - Foley & Lardner LLP
Martin Alexander Gershon, Managing Partner and CIO, Endeavor Venture Funds & Senior Executive Investor-in-Residence Techstars NY powered by J.P. Morgan
View all 2023 Agenda

Our 2023 Sponsors included

Headline Partners


Diamond Sponsors


Gold Sponsors

Silver Sponsors

Bronze Sponsors

Associate Sponsors


Media & Strategic Partners